I believe Manuso is telling the institutional investors about earnings preview in a way not to be caught or being crooked. Like we may have a harder situation going forward since dacogen will be off patent come next year in May. Therefore our revenue might be unexpectedly light.
Just like Septembe's options expiration and announcing the MP-470 will be discontinued. People are behind the scene of everything. and there job is to fool the average investor like freewilly. So how much money have you lost so far freewilly ? And I hope your additional 344 shares that you may have received was all worth your effort.
What will be the low's no one knows. I wouldn't be surprise if we hit $1.30 again, serioulsy. If a generic drug does come out, $1.30 for sure. If not then we go up in revenue and it goes above $3 again. But it will be along time until everyone finds out. Is it worth holding ?